PRLD (PRLD) Stock Price & Analysis
PRLD (PRLD) rose 4.00% to USD 5.46 as of September 8, 2026 at 05:43 UTC, according to Nexqual real-time market data.
PRLD last closed at USD 5.46; the session ranged USD 5.19–5.52 on volume of 400,285 shares. Market capitalization is —, with a 52-week range of USD 0.98–6.83 (NMS). Source: Nexqual, September 8, 2026 at 05:43 UTC.
Key Statistics (as of September 8, 2026 at 05:43 UTC)
| Price | USD 5.46 |
|---|---|
| Change | ▲ 4.00% (up) |
| Previous Close | USD 5.46 |
| Open | USD 5.46 |
| Day Range | USD 5.19 – 5.52 |
| 52-Week Range | USD 0.98 – 6.83 |
| Volume | 400,285 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (PRLD)
Nexqual's technical model rates PRLD "NEUTRAL" based on 3 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 05:43 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 51.3 (neutral) |
| vs SMA50 | Above (USD 5.05) |
| MACD | 0.16 (positive) |
From PRLD's Latest SEC 10-K Filing (filed 2026-03-10)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PMVP | PMV Pharmaceuticals, Inc. | USD 1.29 | ▲ 2.38% |
| STTK | Shattuck Labs, Inc. | USD 6.79 | ▼ 1.74% |
| FHTX | Foghorn Therapeutics Inc. | USD 4.92 | ▼ 4.84% |
| CCCC | C4 Therapeutics, Inc. | USD 3.76 | ▼ 0.79% |
| KYMR | Kymera Therapeutics, Inc. | USD 117.39 | ▼ 1.05% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:43 UTC. This page is informational and not investment advice.